No Detail Found!

Crosslinking neuropharmacology and pathology: Luteolin based therapy in In-Vivo experiments

Author(s)
Binish Anwar Department of Pharmacology, Shalamar Medical and Dental College, Lahore, Pakistan
Pirya Nangdev Department of Pathology, Bilawal Medical College, LUMHS, Jamshoro, Pakistan
Qudsum Yousaf Department of Neurology, Central Park Teaching Hospital, Lahore, Pakistan
Usman Aslam Department of Pharmacology, Akhtar Saeed Medical and Dental College, Lahore, Pakistan
Maryam Mastoor Department of Pharmacology, Amna Inayat Medical College, Lahore, Pakistan
Haseeb Khaliq Department of Pathology, University of Health Sciences, Lahore, Pakistan
Abstract
Objective: To relate the neuroprotective potential of Luteolin within Autism-Induced neurodegenerative rats' model and introducing novel insights of serum Brain-derived neurotrophic factor (BDNF) levels. Methodology: These in-vivo experiments were conducted in the Laboratory of Liaquat University of Medical and Health Sciences, Jamshoro. Twenty-five healthy male rats, seven weeks old, of Sprague-Dawley strain were selected and to categorize them five groups were formed. Group I was the physiological/noninduced rats (n=5) while other groups of various sizes (n=20) were administrated with intraperitoneal injections of propionic acid (250 mg/kg/day for 5 days). Group II (induced with PPA), Groups III, IV, and V used Luteolin at the concentrations of 100 mg/kg, 200 mg/kg, and 400 mg/kg, respectively a regular diet for a total of 24 days. The effect of luteolin was determined in terms of BDNF level by means of ELISA. Statistical analysis was conducted where One-way ANOVA and Post hoc Turkey test was used. Results: The levels of BDNF were observed to be back in the Luteolin treated groups (III, IV and V) as compared with the group (II) inferring that Luteolin therapy can heal the autism like symptoms. The levels of measured BDNF (ng/ml) were as follows, Group I (13.1±0.3), II (5.1 ±0.2), III (9.8±0.3), IV (8.0±0.3) and V (10.1±0.3). The group induced by the treatment with PPA was PPA+200 mg/kg Luteolin. It also showed the differences between the groups using a one-way ANOVA. To be specific, BDNF levels in Groups III, IV and V was higher than in Group II (PPA-induced) as shown by the post-hoc Turkeys test (p<0.05). Conclusion: Luteolin was found to interact with PPA induced Autism Mouse models proportional to the recovery in serum BNDF levels.
Publication Details
Page(s) 950-953
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 49, Issue: 4, Year: 2024

Request the full text from PASTIC

Keywords
PPA, Neurodegeneration, BDNF, Luteolin, propionic acid, autism.
References
Amini F,Amini-Khoei H,Haratizadeh S,Setayesh M,Basiri M,Raeiszadeh M .2023 .Hydroalcoholic extract of Passiflora incarnata improves the autistic-like behaviour and neuronal damage in a valproic acid-induced rat model of autism. J Tradit Complement Med, 13 : 315-24.
Fombonne E,MacFarlane H,Salem AC .2021 .Epidemiological surveys of ASD: advances and remaining challenges. J Autism Dev Disord, 51 : 4271-90.
Kamen CL,Zevy DL,Ward JM,Bishnoi IR,Kavaliers M,Ossenkopp KP .2019 .Systemic treatment with the enteric bacterial fermentation product, propionic acid, reduces acoustic startle response magnitude in rats in a dosedependent fashion: contribution to a rodent model of ASD. Neurotox Res, 35 : 353-9.
Samanta S,Banerjee J,Ahmed R,Dash SK,Prevention Disease .2023 .Potential Benefits of Bioactive Functional Components of Citrus Fruits for Health Promotion. Recent Advances in Citrus Fruits: Springer, : 451-99.
Zhou W,Hu M,Hu J,Du Z,Su Q .2021 .Luteolin suppresses microglia neuroinflammatory responses and relieves inflammation-induced cognitive impairments. Neurotox Res, 39 : 1800-11.
Mokhtari T,Lu M,El-Kenawy AE .2023 .Potential anxiolytic and antidepressant-like effects of luteolin in a chronic constriction injury rat model of neuropathic pain: Role of oxidative stress, neurotrophins, and inflammatory factors. Int Immunopharmacol, 122 : 110520.
Yang Y,Tan X,Xu J,Wang T,Liang T,Xu X .2020 .Luteolin alleviates neuroinflammation via downregulating the TLR4/TRAF6/NF-κB pathway after intracerebral hemorrhage. Biomed Pharmacother, 126 : 110044.
Alhusaini A,Hasan IH,Alrumayyan B,Alesikri M,Alanazi K,Almasoud R .2020 .Neuroprotective efficacy of nano‐CoQ against propionic acid toxicity in rats: Role of BDNF and CREB protein expressions. J. Biochem Mol Toxicol, 34 : e22449.
Wan M,Sun S,Di X,Zhao M,Lu F,Zhang Z .2024 .Icariin improves learning and memory function in Aβ1-42- induced AD mice through regulation of the BDNF-TrκB signaling pathway. J Ethnopharmacol, 318 : 117029.
Martins N,Quispe C,Kirkin C,Senol E,Zulug A,Özçelik B .2021 .Paving Plant-Food-Derived Bioactives as Effective Therapeutic Agents in Autism Spectrum Disorder. Oxid Med Cell Longev, : 1131280.
Abdollahi H,Edalatmanesh MA,Hosseini E,Foroozanfar M. .2021 .The effects of hesperidin on BDNF/TrkB signaling pathway and oxidative stress parameters in the cerebral cortex of the utero-placental insufficiency fetal rat model. Basic Clin Neurosci, 12 : 511-6.
Saad AK,Akour A,Mahboob A,AbuRuz S,Sadek B .2022 .Role of brain modulators in neurodevelopment: focus on autism spectrum disorder and associated comorbidities. Pharmaceuticals, 15 : 612-6.
Alsubaiei SRM,Alfawaz HA,Bhat RS,El-Ansary AJM .2023 .Nutritional Intervention as a Complementary Neuroprotective Approach against Propionic AcidInduced Neurotoxicity and Associated Biochemical Autistic Features in Rat Pups. Metabolites, 13 : 738-42.
Barbosa AG,Pratesi R,Paz GSC,Dos Santos MAAL,Uenishi RH,Nakano EY .2020 .Assessment of BDNF serum levels as a diagnostic marker in children with autism spectrum disorder. Sci Rep, 10 : 17348.
Cichon N,Saluk-Bijak J,Gorniak L,Przyslo L,Bijak MJA .2020 .Flavonoids as a natural enhancer of neuroplasticityAn overview of the mechanism of neurorestorative action. Antioxidants, 9 : 1035.
Guazelli CF,Fattori V,Ferraz CR,Borghi SM,Casagrande R,Baracat MM .2020 .Antioxidant and antiinflammatory effects of hesperidin methyl chalcone in experimental ulcerative colitis. Chemico-biological interactions 2021 Jan, 10 : 109315.
Sharma P,Kumari S,Sharma J,Purohit R,Singh DJ .2021 .Hesperidin interacts with CREB-BDNF signaling pathway to suppress pentylenetetrazole-induced convulsions in zebrafish. Front Pharmacol, : 607797.
Kardani A,Soltani A,Sewell RD,Shahrani M .2019 .Neurotransmitter, antioxidant and antineuroinflammatory mechanistic potentials of herbal medicines in ameliorating autism spectrum disorder. Curr Pharm Des, 25 : 4421-9.
Camuso S,La Rosa P,Fiorenza MT .2022 .Pleiotropic effects of BDNF on the cerebellum and hippocampus: Implications for neurodevelopmental disorders. Neurob Dis, : 105606.
Colucci-D'Amato L,Speranza L,Volpicelli F .2020 .Neurotrophic factor BDNF, physiological functions and therapeutic potential in depression, neurodegeneration, and brain cancer. Int J Mol Sci, 21 : 7777-10.
Kempuraj D,Thangavel R,Kempuraj DD,Ahmed ME,Selvakumar GP,Raikwar SP .2021 .Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma. Biofactors, 47 : 190-7.
0

Citations

0

Downloads

72

Views